Literature DB >> 10670853

Cholecystectomy is an effective treatment for biliary dyskinesia.

F Yost1, J Margenthaler, M Presti, F Burton, K Murayama.   

Abstract

BACKGROUND: An increasing number of reports indicate symptomatic relief of biliary colic symptoms after cholecystectomy for biliary dyskinesia. Despite this, cholecystectomy as a treatment for biliary dyskinesia remains controversial. Our aim was to determine efficacy of cholecystectomy in alleviating biliary dyskinesia symptoms and the correlation with histologic findings.
METHODS: Records of patients with gallbladder ejection fraction <35% between January 1994 and February 1999 were reviewed. Gallbladder pathology and degree of symptomatic improvement were determined on follow-up.
RESULTS: Of the 27 cholecystectomy patients, 24 (89%) had significant improvement, 2 (7%) had partial improvement, and 1 (4%) had minimal improvement. Ten patients (43%) had normal gall-bladder, and 9 (90%) of them had significant improvement after cholecystectomy. Of the 6 nonsurgical patients, none had significant improvement, 4 (67%) had partial improvement, and 2 (33%) had minimal improvement.
CONCLUSIONS: Biliary dyskinesia patients who underwent cholecystectomy had significantly greater symptom improvement compared with nonsurgical patients. Pathologic correlation suggests chronic inflammation may not be the only cause of gallbladder dysfunction. Cholecystectomy should be a first-line therapy for biliary dyskinesia patients.

Entities:  

Mesh:

Year:  1999        PMID: 10670853     DOI: 10.1016/s0002-9610(99)00228-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  24 in total

1.  Normokinetic biliary dyskinesia: a novel diagnosis.

Authors:  Christopher DuCoin; Robert Faber; Marlon Ilagan; William Ruderman; Daryl Wier
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

Review 2.  Controversies concerning pathophysiology and management of acalculous biliary-type abdominal pain.

Authors:  Amit Rastogi; Adam Slivka; Arthur James Moser; Arnold Wald
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Pain provocation and low gallbladder ejection fraction with CCK cholescintigraphy are not predictive of chronic acalculous gallbladder disease symptom relief after cholecystectomy.

Authors:  Michael A Edwards; Benjamin Mullenbach; Sherman M Chamberlain
Journal:  Dig Dis Sci       Date:  2014-05-23       Impact factor: 3.199

4.  Evaluation of gastrointestinal pathology and treatment in children with suspected biliary dyskinesia.

Authors:  Wikrom Karnsakul; Richard Vaughan; Tarun Kumar; Stacey Gillespie; Kathryn Skitarelic
Journal:  Pediatr Surg Int       Date:  2011-06-25       Impact factor: 1.827

Review 5.  Cholecystectomy for biliary dyskinesia: how did we get there?

Authors:  Klaus Bielefeldt; Shreyas Saligram; Susan L Zickmund; Anwar Dudekula; Mojtaba Olyaee; Dhiraj Yadav
Journal:  Dig Dis Sci       Date:  2014-09-06       Impact factor: 3.199

6.  Biliary dyskinesia: a potentially unrecognized cause of abdominal pain in children.

Authors:  Brendan T Campbell; Nathan P Narasimhan; Eustace S Golladay; Ronald B Hirschl
Journal:  Pediatr Surg Int       Date:  2004-08-18       Impact factor: 1.827

7.  Gallbladder ejection fraction and symptom outcome in patients with acalculous biliary-like pain.

Authors:  Nuri Ozden; John K DiBaise
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

Review 8.  Biliary dyskinesia in the pediatric patient.

Authors:  Michael S Halata; Stuart H Berezin
Journal:  Curr Gastroenterol Rep       Date:  2008-06

9.  Laparoscopic cholecystectomy for biliary dyskinesia: correlation of preoperative cholecystokinin cholescintigraphy results with postoperative outcome.

Authors:  J Bingener; M L Richards; W H Schwesinger; K R Sirinek
Journal:  Surg Endosc       Date:  2004-04-02       Impact factor: 4.584

Review 10.  [Acute biliary colic. Etiology, diagnosis and therapy].

Authors:  Birgit Terjung; M Neubrand; T Sauerbruch
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.